Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
- Disease/Condition
- Depression
- Drug/Device/Intervention
- Keto-like supplement
- Study type
- Interventional
- Intervention type
- dietary supplement
- Primary sponsor
- Laureate Institute for Brain Research, Inc.
- Location
- Tulsa, United States of America
- Phase
- Phase 2
- Start date
- Jan 09, 2024
- End date
- Jan 01, 2026
- Enrollment
- 75 participants
BOLD response during Monetary Incentive Delay Task
This study aims to determine whether a keto-like supplement relative to placebo results in
 functional brain changes during fMRI tasks evaluating positive and negative valence in
 individuals with moderate to severe depression. In this double-blind randomized
 placebo-controlled trial, 75 individuals with a Patient Health Questionnaire (PHQ-9) scale
 score ≥ 10 (MDD) will be enrolled to participate in an 8-week treatment study to obtain 60
 completers. Participants will be randomized with a 1-1 ratio to receive the keto-like
 supplement (n= 30 completers) or placebo (n=30 completers) taken orally three times per day
 for 8 weeks. Participants will undergo a 10.5-hour screening/baseline evaluation visit split
 over 2 days at week 0 including questionnaires, neuroimaging before and after supplement or
 placebo administration and blood draws, office visits at week 2 (1.5 hours), week 4 (3
 hours), week 6 (0.5 hours), week 8 (6 hours), a follow-up visit at week 10 (1.5 hours) and
 two phone calls between visits (weeks 1 and 3) during which a brief clinical assessment will
 be obtained (10 minutes each). The total time involved in the study is approximately 23.5
 hours.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06263660
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06263660 through Pure Global AI's free database. This Phase 2 trial is sponsored by Laureate Institute for Brain Research, Inc. and is currently Recruiting. The study focuses on Depression. Target enrollment is 75 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.